AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

44% less call options, than puts

Call options by funds: $23.8M | Put options by funds: $42.2M

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.8M
Puts
$42.2M
Net Calls
Net Calls Change

Top Buyers

1 +$84.6M
2 +$71.2M
3 +$27.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
5
BlackRock
BlackRock
New York
+$16.9M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$3.03M
102
$2.87M
103
$2.87M
104
$2.87M
105
$2.84M
106
$2.75M
107
$2.72M
108
$2.64M
109
$2.63M
110
$2.6M
111
$2.51M
112
$2.46M
113
$2.4M
114
$2.37M
115
$2.37M
116
$2.32M
117
$2.27M
118
$2.21M
119
$2.17M
120
$2.1M
121
$2.09M
122
$2.09M
123
$1.99M
124
$1.98M
125
$1.95M